Angiodynamics (ANGO) Cash from Financing Activities (2016 - 2026)
Angiodynamics' Cash from Financing Activities history spans 17 years, with the latest figure at $621000.0 for Q1 2026.
- For Q1 2026, Cash from Financing Activities fell 91.31% year-over-year to $621000.0; the TTM value through Feb 2026 reached -$5.1 million, down 1089.9%, while the annual FY2025 figure was -$255000.0, 99.6% up from the prior year.
- Cash from Financing Activities reached $621000.0 in Q1 2026 per ANGO's latest filing, up from -$92000.0 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $24.4 million in Q3 2022 to a low of -$59.6 million in Q3 2023.
- Average Cash from Financing Activities over 5 years is -$2.3 million, with a median of $123000.0 recorded in 2022.
- Peak YoY movement for Cash from Financing Activities: plummeted 441.75% in 2023, then soared 929.83% in 2025.
- A 5-year view of Cash from Financing Activities shows it stood at $103000.0 in 2022, then tumbled by 441.75% to -$352000.0 in 2023, then crashed by 219.03% to -$1.1 million in 2024, then skyrocketed by 91.81% to -$92000.0 in 2025, then soared by 775.0% to $621000.0 in 2026.
- Per Business Quant, the three most recent readings for ANGO's Cash from Financing Activities are $621000.0 (Q1 2026), -$92000.0 (Q4 2025), and $143000.0 (Q3 2025).